TersOx Modulator

Hazard statements (CLP)

H290, H314, H335

Code

Statements

H290

May be corrosive to metals

2.1 Classification of the substance or mixture

White or transparent crystalline powder. Noncombustible. At very high temperatures, Sulfur dioxide, sulfur trioxide and ammonia may be generated. No known chronic hazards. None of the components present in this material at concentrations equal to or greater than 0.1% are listed by IARC, NTP, OSHA, or ACGIH as a carcinogen.

Signal word

Danger

Hazard statements

H290 May be corrosive to metals. H314 Causes severe skin burns and eye damage. H335 May cause respiratory irritation. Eye contact may cause eye corrosion with corneal or conjunctival ulceration. Skin contact may cause skin irritation with discomfort or rash. Higher or prolonged skin irritation may cause burns or ulceration. Inhalation may cause irritation of the respiratory passages with cough, difficulty in breathing and bronchial irritation. Ingestion may cause irritation of the gastrointestinal tract with abdominal pain, nausea, vomiting, diarrhea, and abnormal kidney function. Ingestion may also cause corrosion of mucous membranes with stomach discomfort, nausea, and prostration. Individuals with preexisting diseases of the skin, kidneys, or reproductive system may have increased susceptibility to the toxicity of excessive exposure.

Prevention

P234 Keep only in original container. P260 Do not breathe mist / vapors / spray. P264 Wash hands thoroughly after handling. P271 Use only outdoors or in a well-ventilated area. P280 Wear protective gloves / protective clothing / eye protection / face protection. Acute Toxicity Inhalation 4-hour LC50: 7.7 mg/L in rats Oral LD50: 4,240 mg/kg in rats Hazard(s) not otherwise classified (HNOC) None known.

Additional information

The mixture is a skin and eye corrosive but is not a skin sensitizer in animals. Toxic effects described in animals from a single exposure by inhalation include body weight losses, ocular and nasal discharges and other nonspecific effects. Repeated inhalation exposures produced liver, spleen, and thymus changes and gastrointestinal tract alterations. By ingestion, the administration of single high oral doses produced severe gastrointestinal tract irritation, liver damage, increased kidney weights, and the formation of dosing in cats produced weight and appetite loss, depression, vomiting, coma, convulsions, kidney failure due to calcium oxalate deposition, and death. Dogs given similar and higher doses exhibited no toxic effects. Long-term dosing in male and female rats exhibited no toxic effects. At a high dietary level, a reduced number of off-spring were observed in rats, but this effect occurred only at a maternally toxic dose. In a developmental toxicity study, fetal abnormalities were indicated in rats orally dosed during gestation with Synergist at levels that also produced maternal toxicity. The mixture does not produce genetic damage in bacteria cell cultures.